Developing A Vaccine For The ‘Zombie Drug’ Xylazine

Developing A Vaccine For The ‘Zombie Drug’ Xylazine

Eurasia Review

Published

Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids, like fentanyl and heroin, as well as cocaine—leading to a sharp rise in overdose deaths.

Now, Scripps Research chemical biologists have developed a...

Full Article